Status:
UNKNOWN
Puncture Template Assisted Biopsy for Pulmonary Nodules
Lead Sponsor:
Peking University Third Hospital
Conditions:
Pulmonary Nodule
CT Guided Biopsy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Pulmonary nodules are small in size and easy to move with breathing. CT guided puncture is highly dependent on the personal experience of physicians, that is, the accuracy, efficiency and incidence of...
Eligibility Criteria
Inclusion
- Single or multiple pulmonary nodules (solid, partially solid, pure ground glass), with the maximum diameter of 5mm to 20mm and need for pathological diagnosis.
- No drugs affecting blood coagulation and (or) platelet aggregation were used; if used, the drugs had been stopped for enough time according to the drug elution period.
- KPS \> 60, no serious or uncontrollable underlying diseases, the patients can tolerate lung puncture according to clinical evaluation.
- There is an appropriate puncture path.
Exclusion
- Poor lung function (such as FEV1 \< 40% in the first second and / or DLCO \< 50%) and / or isolated pulmonary bullae on the puncture path.
- The nodule is close to small airway and blood vessels, or has pulmonary hypertension and superior vena cava compression, so the risk of puncture bleeding and hemoptysis is expected to be high.
- Poor compliance, unable to complete the cooperation.
- Due to other reasons which is not suitable to participate in this clinical trial.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT04890301
Start Date
June 1 2021
End Date
May 31 2025
Last Update
December 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191